Metabolism of an artificial emulsion resembling chylomicrons in patients with multiple myeloma

Leukemia Research

Volumn 23, Issue 7, 1999, Pages 637-641

  Hungria, Vania T M ^b   Brandizzi, Laura I ^a   Chiattone, Carlos S ^b   Bydlowski, Sergio P ^a   Maranhão, Raul C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Cholesterol; Chylomicrons; Emulsions; Lipoproteins; Multiple myeloma; Triglycerides

Indexed keywords

CHYLOMICRON; LIPID EMULSION; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLEARANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIPID METABOLISM; MALE; MULTIPLE MYELOMA; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0032981690     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00083-1     Document Type: Article

References (28)

1. Legaspi A, Jeevanandam M, Starnes Jr HF, Brennan MF. Whole body lipid and energy metabolism in the cancer patient. Metabolism 1987;36:958.
2. Alexopoulos CG, Blatsios B, Avgerinos A. Serum lipids and lipoprotein disorders in cancer patients. Cancer 1987;60:3065.
3. Maranhão RC, Garicochea B, Silva EL, Llacer PD, Cadena MS, Coelho IJC, Meneghetti JC, Pileggi FJC, Chamone DAF. Plasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia. Cancer Res 1994;54:4660.
4. Dessi S, Baletta B, Spano O, Sanna F, Tonello M, Giacchino M, Tessitore L, Costelli P, Baccino FM, Madon E. Clinical remission is associated with restoration of normal high-density lipoprotein cholesterol levels in children with malignancies. Clin Sci 1995;89:505.
5. Avall-Lundqvist EH, Peterson CO. Serum cholesterol and apolipoprotein B levels may reflect disease activity in ovarian cancer patients. Acta Oncol 1996;35:1007.
6. Gaard M, Tretti S, Urdal P. Blood lipid and lipoprotein levels and the risk of cancer of the colon and rectum. A prospective study of 62 173 Norwegian men and women. Scand J Gastroenterol 1997;32:162.
7. Aviram M, Carter A, Brook JG, Tatarsky I. Chylomicronaemia in multiple myeloma. Scand J Hematol 1985;34:436.
8. Hachem H, Favre G, Soula G. Evidence for qualitative abnormalities in high-density lipoproteins from myeloma patients: the presence of amyloid A protein could explain HDL modifications. Biochim Biophys Acta 1988;963:271.
9. Hungria VTM, Chiattone CS, Barros JC, Latrilha MC, Pileggi F, Chamone DAF, Maranhão RC. Plasma lipids and apolipoproteins in multiple myeloma patients. Blood 1995;86(suppl.1):836a.
10. Fukudome K, Kato J, Ohashi T, Yamamoto Y, Eto T. Hyperlipidemia associated with multiple myeloma. Int Med 1996;35:337.
11. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U, Bisgaier CL. Lipoprotein Apo C-II activation of lipoprotein lipase. Modulation of apolipoprotein A-IV. J Biol Chem 1990;265:4266.
12. Zannis VI, Kardassis D, Zanni EE. Genetic mutations affecting human lipoproteins, their receptors, and their enzymes. In: Harris H, Hirschhorn K, editors. Advances in Human Genetics. New York: Plenum Press, 1993:154.
13. Redgrave TG, Maranhão RC. Metabolism of protein-free lipid emulsion models of chylomicrons in rats. Biochim Biophys Acta 1985;835:104.
14. Oliveira HCF, Hirata MH, Redgrave TG, Maranhão RC. Competition between chylomicrons and their remnants for plasma removal: a study with artificial emulsion models of chylomicrons. Biochim Biophys Acta 1988;958:211.
15. Maranhão RC, Rolan IA, Hirata MH. Effects of Triton WR1339 and heparin on the transfer of surface lipids from triglyceride-rich emulsions to high-density lipoproteins in rats. Lipids 1990;25:701.
16. Maranhão RC, Feres MC, Martins MT, Mesquita CH, Toffoletto O, Vinagre CGC, Gianinni SD, Pileggi F. Plasma kinetics of a chylomicron-like emulsion in patients with coronary artery disease. Atherosclerosis 1996;126:15.
17. Durie BGM, Salmon SE. The current status and future prospects of treatment for multiple myeloma. Clin Hematol 1982;11:181.
18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499.
19. Redgrave TG, Callow MJ. The effect of protein deficiency on the metabolism of lipid emulsion models of triacylglycerol-rich lipoproteins in rats. Metabolism 1993;290:843.
20. Tsuchiya J. Some problems in the laboratory findings in multiple myeloma. Acta Hematol Jap 1989;52:1273.
21. Mays ET. Serum lipids in human cancer. J Surg Res 1969;9:273.
22. Nydegger UE, Butler RE. Serum lipoprotein levels in patients with cancer. Cancer Res 1972;32:1756.
23. Ho YK, Brown MS, Goldstein JL. Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 1978;52:1099.
24. Kawakami M, Murase T, Ogawa H, Ishibashi S, Mori N, Takaku F, Shibata S. Human recombinant TNF supresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells. J Biochem 1987;101:331.
25. Ogawa H, Nielsen S, Kawakami M. Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells. Biochim Biophys Acta 1989;1003:131.
26. Lopez-Soriano J, Llovera M, Carbo N, Garcia-Martinez C, Lopes-Soriano FJ, Argiles FM. Lipid metabolism in tumor-bearing mice: studies with knockout mice for tumor necrosis factor receptor 1 protein. Mol Cell Endocrinol 1997;132:93.
27. Grunfeld C, Soued M, Adi S, Moser AH, Fiers W, Dinarello CA, Feingold KR. Interleukin-4 inhibits stimulation of hepatic lipogenesis by tumor necrosis factor, interleukin-1 and interleukin-6 but not by interferon-alpha. Cancer Res 1991;51:2803.
28. Slyper ADH. A fresh look at the atherogenic remnant hypothesis. Lancet 1992;340:289.